[Articles] Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: a prospective cohort study in Sweden

Diabetes subgroups could inform on outcomes, as well as guide treatment and follow-up needed for newly diagnosed individuals with diabetes. SIRD stands out as a high-risk subgroup that is not identified by conventional glycaemia-based risk factors, but bears risk of early onset end-organ damage and would benefit from identification and treatment before the diagnosis of diabetes.